MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes

NCT01847144 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

143

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Gliclazide 80mg OD
DRUG: Sitagliptin 100mg OD

Sponsor

Royal Devon and Exeter NHS Foundation Trust

Collaborators

[object Object]